O'Connor CM - Search Results

1

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.

Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW; VICTORIA Study Group. Lam CSP, et al. JAMA Cardiol. 2021 Jun 1;6(6):706-712. doi: 10.1001/jamacardio.2020.6455. JAMA Cardiol. 2021. PMID: 33185650 Free PMC article. Clinical Trial.

2

The state of exercise training: a need for action.

Whellan DJ, O'Connor CM. Whellan DJ, et al. Am Heart J. 2002 Jul;144(1):1-4. doi: 10.1067/mhj.2002.123311. Am Heart J. 2002. PMID: 12094180 No abstract available.

3

Diuretic resistance predicts mortality in patients with advanced heart failure.

Neuberg GW, Miller AB, O'Connor CM, Belkin RN, Carson PE, Cropp AB, Frid DJ, Nye RG, Pressler ML, Wertheimer JH, Packer M; PRAISE Investigators. Prospective Randomized Amlodipine Survival Evaluation. Neuberg GW, et al. Am Heart J. 2002 Jul;144(1):31-8. doi: 10.1067/mhj.2002.123144. Am Heart J. 2002. PMID: 12094185 Clinical Trial.

4

Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).

O'Connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman MF, Landolfo KP, Lee KL, Califf RM, Jones RH. O'Connor CM, et al. Am J Cardiol. 2002 Jul 15;90(2):101-7. doi: 10.1016/s0002-9149(02)02429-3. Am J Cardiol. 2002. PMID: 12106836

5

Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure.

Gattis WA, O'Connor CM, Leimberger JD, Felker GM, Adams KF, Gheorghiade M. Gattis WA, et al. Am J Cardiol. 2003 Jan 15;91(2):169-74. doi: 10.1016/s0002-9149(02)03104-1. Am J Cardiol. 2003. PMID: 12521629 Clinical Trial.

6

The problem of decompensated heart failure: nomenclature, classification, and risk stratification.

Felker GM, Adams KF Jr, Konstam MA, O'Connor CM, Gheorghiade M. Felker GM, et al. Am Heart J. 2003 Feb;145(2 Suppl):S18-25. doi: 10.1067/mhj.2003.150. Am Heart J. 2003. PMID: 12594448 Review.

7

Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic heart failure.

O'Connor CM, Gattis WA, Teerlink JR, Adams KF Jr, Gheorghiade M. O'Connor CM, et al. Am Heart J. 2003 Feb;145(2 Suppl):S47-50. doi: 10.1067/mhj.2003.153. Am Heart J. 2003. PMID: 12594451 No abstract available.

8

Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).

O'Connor CM, Gattis WA, Adams KF Jr, Shah MR, Frey A, Gheorghiade M; Randomized Intravenous Tezosentan Study Investigators. O'Connor CM, et al. Am Heart J. 2003 Feb;145(2 Suppl):S58-9. doi: 10.1067/mhj.2003.156. Am Heart J. 2003. PMID: 12594454 Clinical Trial. No abstract available.

9

Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.

Zampino M, O'Connor CM, Gattis WA, Adams KF Jr, Gheorghiade M. Zampino M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S62-6. doi: 10.1067/mhj.2003.158. Am Heart J. 2003. PMID: 12594456 No abstract available.

10

Surrogate end points in heart failure trials.

Gheorghiade M, Adams KF Jr, Gattis WA, Teerlink JR, Orlandi C, O'Connor CM. Gheorghiade M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S67-70. doi: 10.1067/mhj.2003.159. Am Heart J. 2003. PMID: 12594457 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,137 results

Search Page

Filters